These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11377565)

  • 1. Intravenous immunoglobulins in the therapy of severe bacterial infections, immunodeficiencies, and autoimmune diseases.
    Popovic M; Glisic B; Mitrovic D; Stefanovic D; Dimitrijevic M
    Transplant Proc; 2001 May; 33(3):2376-7. PubMed ID: 11377565
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
    Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
    Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous inmunoglobulins in pediatrics].
    Panadero Esteban MI; Carcelén Andrés J; Urbieta Sanz E; Viñuales Armengol MC; Idoipe Tomás A
    Farm Hosp; 2003; 27(3):179-87. PubMed ID: 12835820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy.
    Kaveri SV; Maddur MS; Hegde P; Lacroix-Desmazes S; Bayry J
    Clin Exp Immunol; 2011 Jun; 164 Suppl 2(Suppl 2):2-5. PubMed ID: 21466545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supply, use, and abuse of intravenous immunoglobulin.
    Nowak-Wegrzyn A; Lederman HM
    Curr Opin Pediatr; 1999 Dec; 11(6):533-9. PubMed ID: 10590912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy recommendations for the use of intravenously applicable immunoglobulins].
    Marschner JP; Rietbrock N
    Med Klin (Munich); 1996 Mar; 91(3):141-7. PubMed ID: 8628200
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin therapy: the process, the product, the patient, and the pocketbook. Introduction.
    Harvey RD
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):71S-72S. PubMed ID: 16229676
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intravenous immunoglobulins in dermatology].
    Nydegger U; Hunziker T
    Ann Dermatol Venereol; 2002; 129(8-9):1078-81. PubMed ID: 12442118
    [No Abstract]   [Full Text] [Related]  

  • 9. The patient: Emerging clinical applications of intravenous immunoglobulin.
    Harvey RD
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):85S-93S. PubMed ID: 16229679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic indications of intravenous immunoglobulins].
    Tellier Z; Mouthon L
    Transfus Clin Biol; 2003 Jun; 10(3):179-84. PubMed ID: 12798854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins and their use in children.
    Łaguna P; Gołębiowska-Staroszczyk S; Trzaska M; Grabarczyk M; Matysiak M
    Adv Clin Exp Med; 2015; 24(1):153-9. PubMed ID: 25923100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.
    Clin Pharm; 1992 Feb; 11(2):117-36. PubMed ID: 1312920
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment.
    Raje N; Snyder BL; Hill DA; Streicher JL; Sullivan KE
    Ann Allergy Asthma Immunol; 2018 May; 120(5):537-538.e1. PubMed ID: 29563054
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections.
    Ferrara G; Zumla A; Maeurer M
    Am J Med; 2012 Oct; 125(10):1036.e1-8. PubMed ID: 22608788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and safety of the intravenous immunoglobulin Octagam: a 10-year prospective observational study.
    Debes A; Bauer M; Kremer S
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1038-47. PubMed ID: 17636556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of IVIG in secondary immunodeficiencies].
    Zeman K; Lewandowicz-Uszyńska A
    Postepy Hig Med Dosw; 2002; 56 Suppl():91-102. PubMed ID: 12661419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.
    Bode SF; Ammann S; Al-Herz W; Bataneant M; Dvorak CC; Gehring S; Gennery A; Gilmour KC; Gonzalez-Granado LI; Groß-Wieltsch U; Ifversen M; Lingman-Framme J; Matthes-Martin S; Mesters R; Meyts I; van Montfrans JM; Pachlopnik Schmid J; Pai SY; Soler-Palacin P; Schuermann U; Schuster V; Seidel MG; Speckmann C; Stepensky P; Sykora KW; Tesi B; Vraetz T; Waruiru C; Bryceson YT; Moshous D; Lehmberg K; Jordan MB; Ehl S;
    Haematologica; 2015 Jul; 100(7):978-88. PubMed ID: 26022711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous immunoglobulins in hematologic therapy].
    Giovanelli E
    Clin Ter; 1992 Sep; 141(9 Pt 2):69-73. PubMed ID: 1468201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of secondary immune deficiencies: what is the role of immunoglobulins?
    Mouthon L; Fermand JP; Gottenberg JE
    Curr Opin Allergy Clin Immunol; 2013 Jul; 13 Suppl 2():S56-67. PubMed ID: 23873315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.